1. Home
  2. CLDX vs DNOW Comparison

CLDX vs DNOW Comparison

Compare CLDX & DNOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • DNOW
  • Stock Information
  • Founded
  • CLDX N/A
  • DNOW 1862
  • Country
  • CLDX United States
  • DNOW United States
  • Employees
  • CLDX N/A
  • DNOW N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DNOW Metal Fabrications
  • Sector
  • CLDX Health Care
  • DNOW Industrials
  • Exchange
  • CLDX Nasdaq
  • DNOW Nasdaq
  • Market Cap
  • CLDX 1.6B
  • DNOW 1.6B
  • IPO Year
  • CLDX 2008
  • DNOW N/A
  • Fundamental
  • Price
  • CLDX $26.77
  • DNOW $14.11
  • Analyst Decision
  • CLDX Buy
  • DNOW Buy
  • Analyst Count
  • CLDX 9
  • DNOW 2
  • Target Price
  • CLDX $43.78
  • DNOW $18.00
  • AVG Volume (30 Days)
  • CLDX 958.4K
  • DNOW 1.2M
  • Earning Date
  • CLDX 11-05-2025
  • DNOW 11-06-2025
  • Dividend Yield
  • CLDX N/A
  • DNOW N/A
  • EPS Growth
  • CLDX N/A
  • DNOW N/A
  • EPS
  • CLDX N/A
  • DNOW 0.76
  • Revenue
  • CLDX $5,790,000.00
  • DNOW $2,404,000,000.00
  • Revenue This Year
  • CLDX N/A
  • DNOW $6.19
  • Revenue Next Year
  • CLDX N/A
  • DNOW $3.29
  • P/E Ratio
  • CLDX N/A
  • DNOW $18.54
  • Revenue Growth
  • CLDX N/A
  • DNOW 2.78
  • 52 Week Low
  • CLDX $14.40
  • DNOW $11.54
  • 52 Week High
  • CLDX $29.93
  • DNOW $18.45
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 56.87
  • DNOW 35.90
  • Support Level
  • CLDX $26.10
  • DNOW $13.70
  • Resistance Level
  • CLDX $27.87
  • DNOW $16.26
  • Average True Range (ATR)
  • CLDX 1.18
  • DNOW 0.43
  • MACD
  • CLDX -0.07
  • DNOW -0.15
  • Stochastic Oscillator
  • CLDX 67.91
  • DNOW 11.13

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.

Share on Social Networks: